908 Devices (MASS) Net Income towards Common Stockholders (2020 - 2026)
908 Devices (MASS) reported Net Income towards Common Stockholders of -$12.0 million for Q1 2026, down 127.42% year-over-year from $43.6 million in Q1 2025, and down 5760.29% on a QoQ basis from -$204000.0 in Q4 2025.
908 Devices (MASS) has 7 years of Net Income towards Common Stockholders data on file, last reported at -$12.0 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders fell 127.42% year-over-year to -$12.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$40.4 million (down 2333.63% YoY) and the FY2025 annual result came in at $52.8 million, up 376.75% from the prior year.
- Net Income towards Common Stockholders declined to -$12.0 million in Q1 2026 per MASS's latest filing, from -$204000.0 in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $43.6 million in Q1 2025 and bottomed at -$29.3 million in Q3 2024.
- The 5-year median for Net Income towards Common Stockholders is -$9.4 million (2022), against an average of -$7.2 million.
- The widest annual swing landed in 2024, when Net Income towards Common Stockholders tumbled 313.01%; it then soared 499.4% in 2025.
- Tracing MASS's Net Income towards Common Stockholders over 5 years: stood at -$9.8 million in 2022, then climbed by 24.12% to -$7.4 million in 2023, then soared by 53.94% to -$3.4 million in 2024, then jumped by 94.04% to -$204000.0 in 2025, then sank by 5760.29% to -$12.0 million in 2026.
- Per Business Quant, the three latest MASS Net Income towards Common Stockholders figures stand at -$12.0 million (Q1 2026), -$204000.0 (Q4 2025), and -$15.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | 908 Devices | 314.43 Mn | 202.69 Mn | 6.88 Mn | -11.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.96 Mn |
| Dec 31, 2025 | -204,000.00 |
| Sep 30, 2025 | -14.98 Mn |
| Jun 30, 2025 | -13.31 Mn |
| Mar 31, 2025 | 43.60 Mn |
| Dec 31, 2024 | -3.42 Mn |
| Sep 30, 2024 | -29.30 Mn |
| Jun 30, 2024 | -12.55 Mn |
| Mar 31, 2024 | -10.92 Mn |
| Dec 31, 2023 | -7.43 Mn |
| Sep 30, 2023 | -7.09 Mn |
| Jun 30, 2023 | -9.35 Mn |
| Mar 31, 2023 | -12.53 Mn |
| Dec 31, 2022 | -9.79 Mn |
| Sep 30, 2022 | -6.26 Mn |
| Jun 30, 2022 | -8.10 Mn |
| Mar 31, 2022 | -9.37 Mn |
| Dec 31, 2021 | -3.47 Mn |
| Sep 30, 2021 | -5.19 Mn |
| Jun 30, 2021 | -7.49 Mn |
| Mar 31, 2021 | -6.10 Mn |
| Dec 31, 2020 | -10.24 Mn |
| Sep 30, 2020 | -1.74 Mn |
| Jun 30, 2020 | 1.86 Mn |
| Mar 31, 2020 | -3.00 Mn |